My Companies
Notification
Account
Log Out
Login
NCLT Ahmedabad admitted CIRP against wholly owned subsidiary FTF Pharma for Rs2.18cr operational debt claimed by Immacule Lifesciences, appointing IRP and moratorium. Company says impact unascertainable, evaluating legal options.
Shilpa Medicare Secures SEC Approval For First Extended-Release Ondansetron Injection
Shilpa Medicare Inks Nivolumab Biosimilar Co-Development Deal with Finland's Orion
Shilpa Medicare Commissions Integrated ADC Drug Substance GMP Manufacturing Facility